Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
HOST$3.03+0.10(+3.41%)Before the Midterms, a Debate Over Where Data Centers Belong and Who Pays for Their Power[10:58:38 AM ET]VVOS$0.12-0.00(-3.45%)CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test[10:52:00 AM ET]PPLL$61.17+1.17(+1.95%)Peoples Ltd. Declares Cash and Stock Dividend The Board of Directors of Peoples Ltd. (OTC: PPLL), the parent company of PS Bank, has declared a fourth quarter cash dividend of $0.36 per share and ...[10:44:00 AM ET]MSFT$523.77-7.24(-1.36%)Workhuman Achieves Industry-First Microsoft 365 Certification, Setting a New Standard for Employee Recognition Integrations[10:38:00 AM ET]LINC$22.03+0.31(+1.42%)Lincoln Tech Expands Career Training Program to Address New Jersey’s Skilled Labor Shortage[10:34:57 AM ET]FNF$40.32+1.02(+2.60%)IPX1031 Rolls Out “10-31 Day” Video Starring a Pumpkin with a Property to Pick[10:31:00 AM ET]CTEV$24.28+1.28(+5.57%)Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence[10:30:00 AM ET]DAN$25.86+0.38(+1.49%)Dana Incorporated to Participate in Gabelli 50th Annual Automotive Symposium Dana Incorporated (NYSE: DAN) announced today it will participate in the Gabelli 50th Annual Automotive Symposium on November 3. Beginning at 4 p.m....[10:30:00 AM ET]PPLL$61.17+1.17(+1.95%)Peoples Ltd. Announces Third Quarter Results Peoples Ltd. (OTC: PPLL). Anthony J. Gabello, President and Chief Executive Officer of Peoples Ltd., holding company for PS Bank, has announced...[10:23:00 AM ET]CRML$7.81+0.01(+0.19%)SAGA Metals Positions Wolverine Heavy REE Project Alongside Strange Lake and Tanbreez in Geological Peer Comparison SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTcCQX: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral ...[10:15:00 AM ET]

COSM · NASDAQ

Cosmos Health Inc.

$0.26 +0.01 (+3.26%)

Company overview

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an e-commerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes. It also operates distribution centers in Greece and the United Kingdom, as well as a warehousing facility. Cosmos Health Inc. serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was incorporated in 2009 and is headquartered in Chicago, Illinois.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$26.2M
Employees
149
Headquarters
Chicago, IL
Website
cosmosholdingsinc.com
CEO
Grigorios Siokas
Listed
July 23, 2010
P/E
-0.40
Dividend yield
0.00%

Company financials

Revenue
$69.5M
Gross profit
$7.2M
Operating income
-$17.9M
EBITDA
-$16.9M
Net income
-$21.1M
EPS
-$0.66
Total assets
$62.4M
Total debt
$18.5M
Gross margin
10.40%
Net margin
-30.41%
Earnings yield
-253.08%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

0.150.230.320.410.49
COSM 1D NASDAQ O0.24H0.26L0.24C0.25+0.02 (+6.69%)Vol1.03M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
COSMCosmos Health Inc. Press release Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks ACCESS Newswire
COSMCosmos Health Inc. Press release Noble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price Target ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days ACCESS Newswire
COSMCosmos Health Inc. Press release Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million Accesswire
COSMCosmos Health Inc. Press release Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion Accesswire
COSMCosmos Health Inc. Stock news Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue Accesswire
COSMCosmos Health Inc. Press release Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline Accesswire
COSMCosmos Health Inc. Stock news Reviewing Cosmos Health (NASDAQ:COSM) & Community Health Systems (NYSE:CYH) Defense World
COSMCosmos Health Inc. Stock news Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June Accesswire
COSMCosmos Health Inc. Press release Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market Accesswire
COSMCosmos Health Inc. Press release Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units Accesswire
COSMCosmos Health Inc. Stock news Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market Accesswire
COSMCosmos Health Inc. Press release Cosmos Health: A Company Transformed — 2026 Year-to-Date GlobeNewswire
COSMCosmos Health Inc. Press release Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions GlobeNewsWire
COSMCosmos Health Inc. Press release Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories GlobeNewsWire
COSMCosmos Health Inc. Press release Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term GlobeNewsWire
See more
FAQ

Questions about Cosmos Health Inc.

What does Cosmos Health Inc. do?
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an e-commerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes. It also operates distribution centers in Greece and the United Kingdom, as well as a warehousing facility. Cosmos Health Inc. serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was incorporated in 2009 and is headquartered in Chicago, Illinois.
What is COSM's market cap?
Cosmos Health Inc. (COSM) is a listed stock with a live quote. The latest market cap on this page is $26.2M.
Where is Cosmos Health Inc. headquartered?
Cosmos Health Inc. is headquartered in Chicago, IL.
How do I get COSM news from the API?
Call GET /v1/news?tickers=COSM. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does COSM news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for COSM, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the COSM price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs